Sonova Holding (OTCMKTS:SONVY – Get Free Report) saw a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 58,939 shares, a growth of 428.2% from the October 15th total of 11,158 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 52,624 shares, the days-to-cover ratio is presently 1.1 days.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the company. Jefferies Financial Group raised Sonova from a “moderate sell” rating to a “hold” rating in a research note on Monday. UBS Group lowered shares of Sonova from a “strong-buy” rating to a “hold” rating in a report on Monday, November 2nd. Citigroup reissued a “sell” rating on shares of Sonova in a research report on Friday, July 24th. Royal Bank Of Canada lowered shares of Sonova from a “moderate buy” rating to a “hold” rating in a report on Friday, November 6th. Finally, The Goldman Sachs Group upgraded shares of Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.
Read Our Latest Analysis on Sonova
Sonova Stock Up 2.8%
OTCMKTS:SONVY traded up $1.85 during trading hours on Friday, hitting $68.12. The company had a trading volume of 8,745 shares, compared to its average volume of 29,660. The stock has a 50-day moving average price of $63.01 and a 200 day moving average price of $53.82. Sonova has a 52 week low of $42.26 and a 52 week high of $71.91. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75.
Sonova Company Profile
Sonova is a Switzerland-based hearing care company headquartered in Stäfa. Founded in 1947 as AG für Elektroakustik, it has grown into a global provider of products and services for people with hearing loss. The company develops and sells hearing aids under brands including Phonak and Unitron, as well as cochlear implant systems through Advanced Bionics. Its offerings also include wireless hearing solutions and consumer audio products sold under the Sennheiser brand. Sonova serves customers worldwide through product sales and audiological care services, including hearing assessments, fittings and ongoing support.
Recommended Stories
- Five stocks we like better than Sonova
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
- Firefly Aerospace Lights Up a High-Risk Space Opportunity
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
